Empagliflozin-based quadruple oral therapy for type 2 diabetes: a prospective cohort study

Empagliflozin-based quadruple oral therapy for type 2 diabetes: a prospective cohort study

Abstract The management of Type-2 Diabetes Mellitus (T2DM) remains challenging in cases of poor glycemic control despite triple Oral Hypoglycemic Agent (OHA) therapy. This prospective cohort study aimed to assess the effectiveness of Empagliflozin as part of a quadruple OHA regimen over a 7-year fol...

Full description

Saved in:
Bibliographic Details
Main Authors: Fatemeh Moosaie, Shiva Abedinzadeh, Soghra Rabizadeh, Kimia Daneshvar, Mohammadamin Noorafrooz, Fatemeh Alsadat Mojtahedi, Niloofar Deravi, Seyede Marzie Fatemi Abhari, Akam Ramezani, Alipasha Meysamie, Marzieh Hajibabaei, Sahar Karimpour Reyhan, Mahsa Abbaszadeh, Manouchehr Nakhjavani, Alireza Esteghamati
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Diabetes mellitus, type 2
Drug therapy, Quadruple
Hypoglycemic agents
Online Access:https://doi.org/10.1038/s41598-024-84993-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-024-84993-x

Similar Items